Back
Actinium Pharmaceuticals Vs. Marinus Pharmaceuticals Industry Stock Comparison
Sell
32
ATNM
Actinium Pharmaceuticals
Last Price:
6.55
Seasonality Move:
7.56%
Sell
18
MRNS
Marinus Pharmaceuticals
Last Price:
1.43
Seasonality Move:
4.91%
Sell
32
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $7.06. The Score for ATNM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ATNM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy, Sell or Hold?
- The current Marinus Pharmaceuticals [MRNS] share price is $1.44. The Score for MRNS is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- MRNS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $7.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight selling pressure.
MRNS Stock Price Chart
What is Marinus Pharmaceuticals's stock price today?
-
The Marinus Pharmaceuticals share price today is $1.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight buying pressure.
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 40.94 | Sell |
| Chaikin Money Flow: | -28264 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.44 - 9.16) | Sell |
| Bollinger Bands (100): | (4.99 - 7.95) | Buy |
MRNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.11 | Sell |
| Relative Strength Index (14 RSI): | 14.61 | Sell |
| Chaikin Money Flow: | 645871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.9 - 9.64) | Sell |
| Bollinger Bands (100): | (6.42 - 11.1) | Sell |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.27 | Sell |
| 20-day SMA: | 8.19 | Sell |
| 50-day SMA: | 7.73 | Sell |
| 200-day SMA: | 6.24 | Buy |
| 8-day EMA: | 7.36 | Sell |
| 20-day EMA: | 7.8 | Sell |
| 50-day EMA: | 7.53 | Sell |
| 200-day EMA: | 6.84 | Buy |
MRNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.39 | Buy |
| 20-day SMA: | 5.61 | Sell |
| 50-day SMA: | 7.88 | Sell |
| 200-day SMA: | 8.16 | Sell |
| 8-day EMA: | 2.31 | Sell |
| 20-day EMA: | 4.61 | Sell |
| 50-day EMA: | 6.89 | Sell |
| 200-day EMA: | 8.01 | Sell |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.05 per share, and an increase next year of $1.97 per share.
Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.16 per share, an increase this year of $0.21 per share, and an increase next year of $0.89 per share.
Actinium Pharmaceuticals Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Marinus Pharmaceuticals Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||